- There is a significant difference in the ratio of severe symptoms between the RNA blood positive group (100%) and the RNA blood negative group (23,5%).
- There is a significant difference in the ratio of severe symptoms between the RNA anal swab positive group (72,7%) and the RNA blood negative group (23,5%).
- Both tests could be benefit for disease evolution predictor.
This data comes from a retrospective study including 57 patients with confirmed 2019-nCoV and pneumonia-based diseases. 6 of them were detected to be blood positive. They wanted to investigate if special profiles of virus replication were correlated with patient with severe clinical symptoms.
Chen W., Yuan X., Deng X., Li Y., Cai X., Li L., He R., et al (February 26, 2020). Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Journal Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2020.1732837